| Nr. | Year OPEN | Title | users say> | rate good | rate bad | no link | Citation |
MRSAMupirocinStaphylococcus aureusCeftobiproleFomitesPneumonia (BASKET)Soft tissues (Infection)Panton Valentine leukocidinRifampin| 1 | 2009 | Rapid detection of methicillin-resistant Staphylococcus aureus directly from clinical samples: methods, effectiveness and cost considerations. | 
| + | - | nl | Ger Med Sci 7(-):Doc06 (2009) |
| 2 | 2006 | High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity. | 
| + | - | nl | Arch Intern Med 166(19):2138-44 (2006) |
| 3 | 2004 | Methicillin resistant Staphylococcus aureus in the critically ill. | 
| + | - | nl | Br J Anaesth 92(1):121-30 (2004) |
| 4 | 2005 | Can mupirocin prevent methicillin-resistant Staphylococcus aureus infections? | 
| + | - | nl | Crit Care 9(3):257-8 (2005) Wertheim HF |
| 5 | 2009 | New antimicrobial agents for methicillin-resistant Staphylococcus aureus. | 
| + | - | nl | Crit Care Resusc 11(4):282-6 (2009) |
| 6 | 2003 | Systematic review of isolation policies in the hospital management of methicillin-resistant Staphylococcus aureus: a review of the literature with epidemiological and economic modelling. | 
| + | - | nl | Health Technol Assess 7(39):1-194 (2003) |
| 7 | 2009 | Molecular basis and phenotype of methicillin resistance in Staphylococcus aureus and insights into new beta-lactams that meet the challenge. | 
| + | - | nl | Antimicrob Agents Chemother 53(10):4051-63 (2009) |
| 8 | 2009 | Pharmacodynamics of vancomycin at simulated epithelial lining fluid concentrations against methicillin-resistant Staphylococcus aureus (MRSA): implications for dosing in MRSA pneumonia. | 
| + | - | nl | Antimicrob Agents Chemother 53(9):3894-901 (2009) |
| 9 | 1989 | Methicillin-resistant staphylococci: detection methods and treatment of infections. | 
| + | - | nl | Antimicrob Agents Chemother 33(7):995-9 (1989) |
| 10 | 1989 | Methicillin-resistant staphylococci: genetics and mechanisms of resistance. | 
| + | - | nl | Antimicrob Agents Chemother 33(7):991-4 (1989) |
| 11 | 2009 | Has the publication of methicillin-resistant Staphylococcus aureus (MRSA) treatment guidelines increased the survival associated with MRSA bacteraemia? | 
| + | - | nl | J Antimicrob Chemother 64(5):1111-3 (2009) |
| 12 | 2009 | Nasal decolonization of Staphylococcus aureus with mupirocin: strengths, weaknesses and future prospects. | 
| + | - | nl | J Antimicrob Chemother 64(1):9-15 (2009) |
| 13 | 2008 | Intranasal mupirocin for reduction of Staphylococcus aureus infections in surgical patients with nasal carriage: a systematic review. | 
| + | - | nl | J Antimicrob Chemother 61(2):254-61 (2008) |
| 14 | 2008 | The effect of antibiotics on methicillin-resistant Staphylococcus aureus. | 
| + | - | nl | J Antimicrob Chemother 61(2):246-53 (2008) |
| 15 | 2006 | Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK. | 
| + | - | nl | J Antimicrob Chemother 57(4):589-608 (2006) |
| 16 | 1997 | Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. | 
| + | - | nl | Clin Microbiol Rev 10(4):781-91 (1997) |
| 17 | 1997 | Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. | 
| + | - | nl | Clin Microbiol Rev 10(3):505-20 (1997) |
| 18 | 1988 | Methicillin-resistant staphylococci. | 
| + | - | nl | Clin Microbiol Rev 1(2):173-86 (1988) |
| 19 | 2008 | Current trends in rapid diagnostics for methicillin-resistant Staphylococcus aureus and glycopeptide-resistant enterococcus species. | 
| + | - | nl | J Clin Microbiol 46(5):1577-87 (2008) |
| 20 | 2009 | New therapeutic choices for infections caused by methicillin-resistant Staphylococcus aureus. | 
| + | - | nl | Clin Microbiol Infect 15 Suppl 7(-):44-52 (2009) |
| 21 | 2009 | Do guidelines for the prevention and control of methicillin-resistant Staphylococcus aureus make a difference? | 
| + | - | nl | Clin Microbiol Infect 15 Suppl 7(-):39-43 (2009) |
| 22 | 2009 | Methicillin-resistant Staphylococcus aureus: source control and surveillance organization. | 
| + | - | nl | Clin Microbiol Infect 15 Suppl 7(-):31-8 (2009) |
| 23 | 2009 | Methicillin-resistant Staphylococcus aureus in long-term-care facilities. | 
| + | - | nl | Clin Microbiol Infect 15 Suppl 7(-):26-30 (2009) |
| 24 | 2009 | Community-acquired methicillin-resistant Staphylococcus aureus: what do we need to know? | 
| + | - | nl | Clin Microbiol Infect 15 Suppl 7(-):17-25 (2009) |
| 25 | 2009 | Methods for screening for methicillin-resistant Staphylococcus aureus carriage. | 
| + | - | nl | Clin Microbiol Infect 15 Suppl 7(-):10-6 (2009) |
| 26 | 2009 | Low-level glycopeptide resistance in methicillin-resistant Staphylococcus aureus and how to test it. | 
| + | - | nl | Clin Microbiol Infect 15 Suppl 7(-):2-9 (2009) |
| 27 | 2009 | Management of methicillin-resistant Staphylococcus aureus infections. | 
| + | - | nl | Clin Microbiol Infect 15(2):125-36 (2009) |
| 28 | 2009 | Prevention and control of methicillin-resistant Staphylococcus aureus. | 
| + | - | nl | Clin Microbiol Infect 15(2):120-4 (2009) |
| 29 | 2009 | Laboratory tools and strategies for methicillin-resistant Staphylococcus aureus screening, surveillance and typing: state of the art and unmet needs. | 
| + | - | nl | Clin Microbiol Infect 15(2):112-9 (2009) |
| 30 | 2009 | New insights concerning methicillin-resistant Staphylococcus aureus disease. | 
| + | - | nl | Clin Microbiol Infect 15(2):109-11 (2009) |
| 31 | 2008 | Methicillin-resistant Staphylococcus aureus: risk assessment and infection control policies. | 
| + | - | nl | Clin Microbiol Infect 14(5):407-10 (2008) |
| 32 | 2008 | New and emerging treatment of Staphylococcus aureus infections in the hospital setting. | 
| + | - | nl | Clin Microbiol Infect 14 Suppl 3(-):32-41 (2008) |
| 33 | 2007 | National guidelines for the control and prevention of methicillin-resistant Staphylococcus aureus--what do they tell us? | 
| + | - | nl | Clin Microbiol Infect 13(9):846-53 (2007) |
| 34 | 2007 | The molecular evolution of methicillin-resistant Staphylococcus aureus. | 
| + | - | nl | Clin Microbiol Infect 13(3):222-35 (2007) |
| 35 | 2006 | Control of endemic methicillin-resistant Staphylococcus aureus--recent advances and future challenges. | 
| + | - | nl | Clin Microbiol Infect 12(12):1154-62 (2006) |
| 36 | 2005 | Methicillin-resistant Staphylococcus aureus: clinical manifestations and antimicrobial therapy. | 
| + | - | nl | Clin Microbiol Infect 11 Suppl 4(-):33-42 (2005) |
| 37 | 2005 | Effectiveness of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers at hospital admission to prevent hospital-acquired MRSA infections. | 
| + | - | nl | Clin Microbiol Infect 11(6):457-65 (2005) |
| 38 | 2008 | Pathogenesis of methicillin-resistant Staphylococcus aureus infection. | 
| + | - | nl | Clin Infect Dis 46 Suppl 5(-):S350-9 (2008) |
| 39 | 1995 | Molecular evolution of MRSA. | 
| + | - | nl | Microbiol Immunol 39(8):531-43 (1995) |
| 40 | 2010 | Revisiting Methicillin-Resistant Staphylococcus aureus Infections. | 
| + | - | nl | J Glob Infect Dis 2(1):49-56 (2010) |
| 41 | 2009 | How does healthcare worker hand hygiene behaviour impact upon the transmission of MRSA between patients?: an analysis using a Monte Carlo model. | 
| + | - | nl | BMC Infect Dis 9(-):64 (2009) |
| 42 | 2001 | Molecular epidemiology of methicillin-resistant Staphylococcus aureus. | 
| + | - | nl | Emerg Infect Dis 7(2):323-6 (2001) |
| 43 | 2008 | Methicillin-resistant Staphylococcus aureus: a primer for dentists. | 
| + | - | nl | J Am Dent Assoc 139(10):1328-37 (2008) |
| 44 | 2008 | Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men. | 
| + | - | nl | Ann Intern Med 148(4):249-57 (2008) Diep BA |
| 45 | 2006 | The growing menace of community-acquired methicillin-resistant Staphylococcus aureus. | 
| + | - | nl | Ann Intern Med 144(5):368-70 (2006) Moellering RC Jr |
| 46 | 2006 | Optimal therapy for methicillin-resistant Staphylococcus aureus pneumonia: what is the best dosing regimen? | 
| + | - | nl | Chest 130(4):938-40 (2006) |
| 47 | 2008 | Impact of methicillin resistance on mortality in Staphylococcus aureus VAP: a systematic review. | 
| + | - | nl | Eur Respir J 31(3):625-32 (2008) |
| 48 | 2005 | Methicillin-resistant Staphylococcus aureus: past, present, and--too much of a--future. | 
| + | - | nl | Isr Med Assoc J 7(3):194-6 (2005) |
| 49 | 2009 | Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era. | 
| + | - | nl | J Clin Invest 119(9):2464-74 (2009) |
| 50 | 2007 | Methicillin-resistant Staphylococcus aureus: the latest health scare. | 
| + | - | nl | Mayo Clin Proc 82(12):1463-7 (2007) |
| 51 | 2005 | Epidemiology, treatment, and prevention of community-acquired methicillin-resistant Staphylococcus aureus infections. | 
| + | - | nl | Mayo Clin Proc 80(9):1201-7; quiz 1208 (2005) Kowalski TJ |
| 52 | 2002 | Methicillin resistant Staphylococcus aureus (MRSA) in the intensive care unit. | 
| + | - | nl | Postgrad Med J 78(921):385-92 (2002) |
| 53 | 2005 | External ocular infections due to methicillin-resistant Staphylococcus aureus (MRSA). | 
| + | - | nl | Eye (Lond) 19(3):284-91 (2005) |
| 54 | 2010 | Serious infections caused by methicillin-resistant Staphylococcus aureus. | 
| + | - | nl | Clin Infect Dis 51 Suppl 2(-):S183-97 (2010) |
| 55 | 2010 | Staphylococcus aureus: methicillin-susceptible S. aureus to methicillin-resistant S. aureus and vancomycin-resistant S. aureus. | 
| + | - | nl | Clin Infect Dis 51 Suppl 2(-):S176-82 (2010) |
| 56 | 2010 | Screening and decolonization: does methicillin-susceptible Staphylococcus aureus hold lessons for methicillin-resistant S. aureus? | 
| + | - | nl | Clin Infect Dis 51(5):585-90 (2010) |
| 57 | 2010 | Prevention and control of methicillin-resistant Staphylococcus aureus: dealing with reality, resistance, and resistance to reality. | 
| + | - | nl | Clin Infect Dis 50(2):218-20 (2010) Jarvis WR |
| 58 | 2007 | Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. | 
| + | - | nl | Clin Infect Dis 45 Suppl 3(-):S184-90 (2007) |
| 59 | 2007 | Reading the tea leaves or deciphering DNA microarrays: are certain methicillin-resistant Staphylococcus aureus clones adapted to cause specific infections? | 
| + | - | nl | Clin Infect Dis 44(4):502-5 (2007) Seybold U |
| 60 | 2009 | Eradication of methicillin-resistant Staphylococcus aureus carriage: a systematic review. | 
| + | - | nl | Clin Infect Dis 48(7):922-30 (2009) |
| 61 | 2008 | Ceftobiprole: a new option for treatment of skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus. | 
| + | - | nl | Clin Infect Dis 46(5):656-8 (2008) Widmer AF |
| 62 | 2008 | Clinical practice: colonization, fomites, and virulence: rethinking the pathogenesis of community-associated methicillin-resistant Staphylococcus aureus infection. | 
| + | - | nl | Clin Infect Dis 46(5):752-60 (2008) |
| 63 | 2008 | Current treatment options for community-acquired methicillin-resistant Staphylococcus aureus infection. | 
| + | - | nl | Clin Infect Dis 46(7):1032-7 (2008) |
| 64 | 2008 | Management of methicillin-resistant Staphylococcus aureus bacteremia. | 
| + | - | nl | Clin Infect Dis 46 Suppl 5(-):S386-93 (2008) |
| 65 | 2008 | Pneumonia caused by methicillin-resistant Staphylococcus aureus. | 
| + | - | nl | Clin Infect Dis 46 Suppl 5(-):S378-85 (2008) |
| 66 | 2008 | Skin and soft-tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus. | 
| + | - | nl | Clin Infect Dis 46 Suppl 5(-):S368-77 (2008) |
| 67 | 2008 | Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains. | 
| + | - | nl | Clin Infect Dis 46 Suppl 5(-):S360-7 (2008) |
| 68 | 2008 | The use of active surveillance cultures in adult intensive care units to reduce methicillin-resistant Staphylococcus aureus-related morbidity, mortality, and costs: a systematic review. | 
| + | - | nl | Clin Infect Dis 46(11):1717-25 (2008) McGinigle KL |
| 69 | 2008 | Fact, fiction, or no data: what does surveillance for methicillin-resistant Staphylococcus aureus prevent in the intensive care unit? | 
| + | - | nl | Clin Infect Dis 46(11):1726-8 (2008) |
| 70 | 2009 | Vancomycin in combination with other antibiotics for the treatment of serious methicillin-resistant Staphylococcus aureus infections. | 
| + | - | nl | Clin Infect Dis 49(7):1072-9 (2009) |
| 71 | 2009 | Mupirocin resistance. | 
| + | - | nl | Clin Infect Dis 49(6):935-41 (2009) |
| 72 | 2008 | Role of folate antagonists in the treatment of methicillin-resistant Staphylococcus aureus infection. | 
| + | - | nl | Clin Infect Dis 46(4):584-93 (2008) |
| 73 | 2007 | An outbreak of severe infections with community-acquired MRSA carrying the Panton-Valentine leukocidin following vaccination. | 
| + | - | nl | PLoS One 2(9):e822 (2007) |
| 74 | 2007 | Antibiotic resistant Staphylococcus aureus: a paradigm of adaptive power. | 
| + | - | nl | Curr Opin Microbiol 10(5):428-35 (2007) |
| 75 | 2008 | Clones and drones: do variants of Panton-Valentine leukocidin extend the reach of community-associated methicillin-resistant Staphylococcus aureus? | 
| + | - | nl | J Infect Dis 197(2):175-8 (2008) |
| 76 | 2008 | Understanding the success of methicillin-resistant Staphylococcus aureus strains causing epidemic disease in the community. | 
| + | - | nl | J Infect Dis 197(2):179-82 (2008) Gorwitz RJ |
| 77 | 2010 | Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. | 
| + | - | nl | Clin Microbiol Rev 23(3):616-87 (2010) |
| 78 | 2010 | Rifampin combination therapy for nonmycobacterial infections. | 
| + | - | nl | Clin Microbiol Rev 23(1):14-34 (2010) |
| 79 | 2007 | Combating the growing problem of methicillin-resistant Staphylococcus aureus: do the newer antibiotics represent a better alternative to vancomycin? | 
| + | - | nl | Expert Rev Anti Infect Ther 5(3):333-5 (2007) |
| 80 | 2007 | Community-associated MRSA: a dangerous epidemic. | 
| + | - | nl | Future Microbiol 2(5):457-9 (2007) |
| 81 | 2008 | Who's winning the war? | 
| + | - | nl | J Antimicrob Chemother 62 Suppl 3(-):iii3-6 (2008) |
| 82 | 2005 | Guidelines for the laboratory diagnosis and susceptibility testing of methicillin-resistant Staphylococcus aureus (MRSA). | 
| + | - | nl | J Antimicrob Chemother 56(6):1000-18 (2005) |
| 83 | 2008 | Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis. | 
| + | - | nl | J Antimicrob Chemother 61(1):26-38 (2008) |
| 84 | 2008 | Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community. | 
| + | - | nl | J Antimicrob Chemother 61(5):976-94 (2008) |
| 85 | 2009 | Methicillin-resistant Staphylococcus aureus strain USA300: origin and epidemiology. | 
| + | - | nl | J Antimicrob Chemother 64(3):441-6 (2009) |
| 86 | 2008 | Methicillin-resistant Staphylococcus aureus infections. | 
| + | - | nl | Top HIV Med 16(5):151-5 (2008) |